+34 697 878 137
Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study

Prediction of complicated disease course for children newly diagnosed with Crohn’s disease: a multicentre inception cohort study

ARTICLE

Authors: Subra Kugathasan, Lee A Denson, Thomas D Walters, Mi-Ok Kim, Urko M Marigorta, Melanie Schirmer, Kajari Mondal, Chunyan Liu, Anne Griffiths, Joshua D Noe, Wallace V Crandall, Scott Snapper, Shervin Rabizadeh, Joel R Rosh, Jason M Shapiro, Stephen Guthery, David R Mack, Richard Kellermayer, Michael D Kappelman, Steven Steiner, Dedrick E Moulton, David Keljo, Stanley Cohen, Maria Oliva-Hemker, Melvin B Heyman, Anthony R Otley, Susan S Baker, Jonathan S Evans, Barbara S Kirschner, Ashish S Patel, David Ziring, Bruce C Trapnell, Francisco A Sylvester, Michael C Stephens, Robert N Baldassano, James F Markowitz, Judy Cho, Ramnik J Xavier, Curtis Huttenhower, Bruce J Aronow, Greg Gibson, Jeffrey S Hyams, Marla C Dubinsky.

Published: April 29, 2017 / THE LANCET

Check out the paper here

VIDEO ABSTRACT

Production Company: In Motion Science / 2017

Ibrutinib for patients with rituximab-refractory Waldenström’s macroglobulinaemia (iNNOVATE)

Ibrutinib for patients with rituximab-refractory Waldenström’s macroglobulinaemia (iNNOVATE)

ARTICLE

Authors: Meletios A Dimopoulos, Judith Trotman, Alessandra Tedeschi, Jeffrey V Matous, David Macdonald, Constantine Tam, Olivier Tournilhac, Shuo Ma, Albert Oriol, Leonard T Heffner, Chaim Shustik, Ramón García-Sanz, Robert F Cornell, Carlos Fernández de Larrea, Jorge J Castillo, Miquel Granell, Marie-Christine Kyrtsonis, Veronique Leblond, Argiris Symeonidis, Efstathios Kastritis, Priyanka Singh, Jianling Li, Thorsten Graef, Elizabeth Bilotti, Steven Treon, Christian Buske. On behalf of the iNNOVATE Study Group and the European Consortium for Waldenström’s Macroglobulinemia.

Published: December 9, 2016 / LANCET ONCOLOGY

Check out the paper here

VIDEO ABSTRACT

Production Company: In Motion Science / 2017

Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly

Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly

ARTICLE

Authors: Francesco Passamonti, Martin Griesshammer, Francesca Palandri, Miklos Egyed, Giulia Benevolo, Timothy Devos, Jeannie Callum, Alessandro M Vannucchi, Serdar Sivgin, Caroline Bensasson, Mahmudul Khan, Nadjat Mounedji, Guray Saydam.

Published: December 1, 2016 / LANCET ONCOLOGY

Check out the paper here

VIDEO ABSTRACT

Production Company: In Motion Science / 2017